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ProteinWe have generated a quantitative transcription proﬁle of human bocavirus type 1 (HBoV1) by transfecting a
nearly full-length clone in human lung epithelial A549 cells as well as in a replication competent system in
293 cells. The overall transcription proﬁle of HBoV1 is similar to that of two other members of genus
Bocavirus, minute virus of canines and bovine parvovirus 1. In particular, a spliced NS1-transcript that was
not recognized previously expressed the large non-structural protein NS1 at approximately 100 kDa; and the
NP1-encoding transcripts were expressed abundantly. In addition, the protein expression proﬁle of human
bocavirus type 2 (HBoV2) was examined in parallel by transfection of a nearly full-length clone in A549 cells,
which is similar to that of HBoV1. Moreover, our results showed that, unlike human parvovirus B19 infection,
expression of the HBoV1 proteins only does not induce cell cycle arrest and apoptosis of A549 cells.ogy, Molecular Genetics and
ail Stop 3029, 3901 Rainbow
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Human Bocavirus (HBoV) is one of the recently identiﬁed
respiratory viruses, and tentatively is classiﬁed in the genus Bocavirus
within the subfamily of Parvovirinae of the Parvoviridae family
(Cotmore and Tattersall, 2005). Other members in the Bocavirus
genus are bovine parvovirus type 1 (BPV1) (Chen et al., 1986), minute
virus of canines (MVC) (Schwartz et al., 2002). Different species of
HBoV have been identiﬁed in humans including the prototype HBoV
in respiratory samples as well as HBoV2 and HBoV3 in feces (Kapoor
et al., 2009; Arthur et al., 2009).
HBoV1 was initially identiﬁed from nasopharyngeal aspirates of
patients with lower respiratory infections (Allander et al., 2005). The
HBoV1 genome has been frequently detected worldwide, ranging
from 2% to 19% in respiratory specimens from children under 2 years
old with acute respiratory illnesses (Allander et al., 2005; Arden et al.,
2006; Arnold et al., 2006; Bastien et al., 2006; Choi et al., 2006;
Foulongne et al., 2006; Ma et al., 2006; Sloots et al., 2006; Weissbrich
et al., 2006; Lin et al., 2007, 2008). HBoV1 is associated with acute
expiratory wheezing and pneumonia (Allander et al., 2007; Kahn,
2008; Schildgen et al., 2008), and is commonly detected in association
with other respiratory viruses (Kahn, 2008; Schildgen et al., 2008).However, HBoV1 acute infection with high viral loads in respiratory
samples (N10,000 copies/ml) and increased IgG or IgM detection have
been frequently associated with acute respiratory illnesses (Allander
et al., 2005; Kantola et al., 2008), which indicates an apparent
etiological link to respiratory illnesses. In addition to respiratory
illnesses, HBoV1 is associated with gastroenteritic diseases (Lee et al.,
2007; Arnold et al., 2006; Lau et al., 2007; Vicente et al., 2007;
Albuquerque et al., 2007), a characteristic that shares with two closely
related animal bocaviruses. The largest genome of HBoV1 that has
been sequenced is 5299 nts, which lacks both termini; therefore, it is
not infectious. To date, both termini of the HBoV genome have not
been sequenced; therefore, an HBoV1 infectious DNA clone has not
been described. Recently, new species of human Bocavirus, HBoV2 and
HBoV3, were identiﬁed in human stool specimens. HBoV2 has a
genomic organization identical to that of HBoV1, but the HBoV2 NS1,
NP1, and VP1 proteins have only 78%, 67%, and 80% identity to those of
HBoV1, respectively. Further studies are necessary, however, to
identify potential associations of HBoV2 and HBoV3 with clinical
symptoms or disease (Kapoor et al., 2009; Arthur et al., 2009).
A cell culture system of HBoV1 infection has been recently
established (Dijkman et al., 2009); however, it is inefﬁcient in that
HBoV1 transcripts were only detected by reverse-transcription (RT)-
PCR. Six transcripts of HBoV1 were identiﬁed from HBoV1-infected
differentiated human airway epithelial cells (Dijkman et al., 2009).
The abundance of these transcripts and their coding capabilities are
not yet understood. Two non-structural proteins NS1 and NP1 were
predicted, but the NS1 seems to lack the C-terminus compared to the
full length NS1 of BPV1 and MVC (Qiu et al., 2007; Sun et al., 2009).
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no.: FJ214110) shows 52.6% identity to HBoV1, while the NS1, NP1
and VP1 proteins of MVC are 38.5%, 39.9% and 43.7% identical to those
of HBoV1, respectively (Sun et al., 2009). We have previously
determined the transcription proﬁles of the BPV1 and MVC during
infection (Qiu et al., 2007; Sun et al., 2009). In BPV1, the left ORF
encodes the non-structural protein NS1, at approximately 100 kDa,
and proteins at relatively small sizes are proposed as NS2 (Qiu et al.,
2007; Lederman et al., 1987). The mid-ORF is thought to encode the
BPV1 abundant non-structural protein NP1 at 28 kDa, and the right
ORF contains the coding sequences for the overlapping capsid protein
genes VP1 and VP2 (Qiu et al., 2007; Lederman et al., 1987). Both the
NS1 and NP1 of MVC are important in DNA replication of MVC (Sun
et al., 2009). The NP1 of HBoV1 and BPV1 can supplement the lack of
function of the MVC NP1 in replication of an NP1 knock-out MVC
infectious clone to some degree (Sun et al., 2009); however, the NP1
proteins of the bocaviruses share no similarity to any proteins of the
other parvoviruses. Detection of HBoV proteins either during infection
or in transfection has not been reported.
In this study, we generated a comprehensive transcription proﬁle
of HBoV1 by transfecting a replicative chimeric HBoV1 genome in 293
cells and a non-replicative genome in A549 cells. We studied the
expression proﬁles of both the structural and non-structural proteins
of HBoV in detail. Transcripts encoding the left ORF (NS1) are either
spliced or unspliced at a small intron that lies in the middle of the
genome. Thus, the spliced transcripts are able to encode a large
nonstructural protein NS1 at approximately 100 kDa, which is
comparable to the NS1 of MVC and BPV1; while the unspliced
transcripts encode a relatively small nonstructural protein NS1-70 at
approximately 70 kDa.
Results
Determine the relative abundance of HBoV1 transcripts by RNase
protection assay (RPA)
A transcription map of the HBoV1 has been reported, which was
obtained from HBoV1 RNA isolated from HBoV1-infected differentiated
human airway epithelial cells (Dijkman et al., 2009). In that report, the
HBoV1 transcripts were identiﬁed by reverse transcription (RT)-PCR;
therefore, the relative abundance of the individual transcripts could not
be determined. In other parvovirus systems, little difference has been
seen between viral infection and plasmid transfection (Qiu et al., 2002,
2005, 2007; Sun et al., 2009). Therefore, we decided to examine the
HBoV1 transcription proﬁle in detail by transfection. To this end, we
constructed an HBoV1 plasmid (pHBoV1) containing the full HBoV1
coding sequence (nt 1–5299) by amplifying a nearly full-length genome
from anHBoV1-positive nasopharyngeal aspirate sample. The sequence
of this clone was deposited in Genbank (access no.: GQ925675). We
have found previously that the status of replication alters the
transcription proﬁle of human parvovirus B19 (B19V) (Guan et al.,
2008). To observe the transcriptional proﬁle in a replication-competent
system, we inserted the HBoV1 genome into adeno-associated virus
type 5 (AAV5) inverted terminal repeats (ITRs) so that it could be
replicated while AAV5 Rep78 and necessary Ad5 genes were provided
(Guan et al., 2008) in 293 cells (data not shown).
We used mRNAs isolated from two sources for transcript mapping:
those from A549 cells transfected with pHBoV1, and those from 293
cells transfected with p5TRHBoV1/pHIVAV5Rep78/phelper. RT-PCR
and 5′/3′ RACE were performed as previously described (Qiu et al.,
2002, 2005, 2007; Sun et al., 2009), and gel puriﬁed PCR fragmentswere
further sequenced (data not shown). The RNA landmarks determined
by transfection of p5TRHBoV1 in 293 cells, which were the same as
those determined by transfection of pHBoV1 in A549 cells, are depicted
and diagramed to scale in Fig. 1A. These landmarks basically conﬁrmed
the transcription units as identiﬁed in the previously reported virusinfection system (Dijkman et al., 2009), with the exception of an extra
splice site (A1-1) in the ﬁrst intron. This A1-1 splice site is present in
BPV1 RNA during BPV1 infection (Qiu et al., 2007), but not in MVC RNA
from MVC infection (Sun et al., 2009).
To determine the relative abundance of each HBoV1 mRNA, we
used seven anti-sense HBoV1 probes to protect individual HBoV1
mRNA. A schematic diagram of the seven anti-sense HBoV1 probes
with their putative protected bands and nucleotide numbers (nt) is
shown in Fig. 1A.
Probe PD1
Probe PD1, spanning the putative promoter (P3) and the ﬁrst
donor site (D1), protected bands of 133 and 55 nts. These bands
mapped the RNA initiation site at nt 187 and the ﬁrst splice donor site
(D1) at nt 242. Similar to that of BPV1 andMVC, the ﬁrst exon of HBoV
is short, containing only 55 nts (Fig. 1B, lane 2). Approximately 75% of
HBoV1 RNAs were spliced at the D1 donor site. Multiple bands
centralized at nt 55 were considered as spliced RNA (Qiu et al., 2002).
Probe PA1-1
Probe PA1-1, spanning the ﬁrst acceptor site of the ﬁrst intron (A1-
1), protected bands of 182 and 120 nts (Fig. 1B, lane 3). The 120-nt
bandmapped the ﬁrst 3′ splice acceptor site at nt 920, which is similar
to the location of the acceptor site in BPV1 RNA. In addition, as seen in
BPV1, only a small portion of RNAs, less than 10% of spliced RNA at the
D1 donor site, were spliced at the A1-1 acceptor site (Qiu et al., 2007).
Probe PA1-2 and PA1-2/D2
Probe PA1-2, spanning the second acceptor of the ﬁrst intron (A1-2),
protected bands of 162 and 117 nts (Fig. 1C, lane 2). Probe PA1-2/D2,
spanning the second acceptor of the ﬁrst intron (A1-2) and the donor
site of the small intron (D2), protected bands of 225, 122 and 168 nts
(Fig. 1C, lane 3). These bands protected from both probes conﬁrmed the
location of the A1-2 acceptor and the D2 donor at nt 2043 and nt 2165,
respectively. Similar to BPV1 and MVC, the majority of HBoV1 RNAs
protected by probe PA1-2/D2were spliced at both sites, resulting in the
abundant band present at 122 nts (approximately 90%). Only approx-
imately 5% of RNAs in this region were unspliced at the A1-2 acceptor
site, which resulted in the band at 168 nts (spliced at D2) and the band
at 225 nts (unspliced at D2). Interestingly, this probe did not detect
RNAs that were spliced at A1-2 and remained unspliced at the D2 site
(which would have generated a band at 181 nts).
Probe A2/D3
Probe PA2/D3, which spans the A2 acceptor and the D3 donor sites,
protected bands at 241, 123, 192 and 167 nts. These bands conﬁrmed
theusage of theA2site atnt2235and theD3site atnt2358(Fig. 1D, lane
2). Approximatelyhalf of theRNAs that spliced the small intron (D2–A2)
were not further spliced at the third intron (D3–A3), which resulted in
the 192-nt band; another half were spliced at D3, which resulted in the
123-nt band. These splicedmRNAs at123 nts (spliced atbothA2andD3,
Fig. 1D, lane 2) represent capsid protein-encoding mRNAs, which
account for one third of the RNAs protected by probe A2/D3. Only a
minor portion of RNAs, at a size of 167 nts, were unspliced at the A2 site
and spliced at the D3 site (Fig. 1D, lane 2), which was not seen in RNAs
from transfected A549 cells (data not shown); therefore, we did not
include this transcript in the ﬁnal transcription proﬁle.
Probe PA3
Probe PA3, which spans the A3 acceptor site, protected two bands
at 159 and 107 nts. Thus the A3 acceptor site was mapped to nt 2995
Fig. 1. Transcription mapping of HBoV1 RNA by RPA. (A) Schematic diagram of the HBoV1 genome and the probes used for RPA. The landmarks of transcription: the promoter (P3),
the splice donor sites (D1, D2, and D3), the acceptor sites (A1-1, A1-2, A2 and A3), the internal polyadenylation signal (pA)p and the distal polyadenylation site (pA)d, which were
identiﬁed by RT-PCR and RACE, are shown. The RPA probes PD1 (nt 161 to 320), PA1-1 (nt 854 to 1040), PA1-2 (nt 1998–2160), PA1-2/D2 (1998–2223), PA2/D3 (nt 2191–2432),
PA3 (nt 2961–3120) and p(pA)p (nt 3291–3440) are shown, along with the designated bands they are expected to protect and their predicted sizes. (B, C, D and E) Mapping of the
HBoV1 transcription map by RPA. Ten µg of total RNA isolated 2 days from p5TRHBoV1-transfected 293 cells was protected by the above described probes, in individual reactions as
indicated. Lane 1, 32P-labeled RNA markers (Qiu et al., 2002), with sizes indicated to the left. The origins of the protected bands in the lanes are indicated. Spl, spliced RNAs; Unspl,
unspliced RNAs; RT, RNAs read through the (pA)p site; (pA)p, polyadenylated RNAs at (pA)p.
147A.Y. Chen et al. / Virology 403 (2010) 145–154(Fig. 1E, lane 2). The ratio of unspliced to spliced RNA across this
region was approximately 1:1.
Probe P(pA)p
Probe P(pA)p was used to map the internal poly A signal (pA)p
(Fig. 1E, lane 3). The band at 108 ntsmapped the cleavage site at 3406,
consistent with the site identiﬁed by 3′RACE (data not shown). Theratio of RNAs that read-through vs. those polyadenylated at (pA)pwas
approximately 1:1. The AAUAAA at nt 3232 was not used (data not
shown).
Northern blot analysis of HBoV1 RNA
From the results obtained from RT-PCR and RPA, we obtained a
preliminary transcription map of HBoV1 expression by transfection
148 A.Y. Chen et al. / Virology 403 (2010) 145–154(Fig. 2B). We next sought to determine the abundance of these HBoV1
transcripts by Northern blot analysis using three probes that are
schematically diagramed at the bottom of Fig. 2B.
Hybridization of HBoV1 RNAs, either from 293 cells (replication-
competent) or A549 cells, with the Cap probe revealed HBoV1
transcripts that were polyadenylated at the (pA)d site (Fig. 2A, lanes 2
and 3). These transcripts were the 4.8 kb R2M mRNA and the 4.9 kb
R2m mRNA, which putatively encode NS1, the 3.0 kb R4 mRNA—
putatively encoding NP1 as well as the 2.4 kb R5 mRNA—putatively
encoding capsid protein VP1 and VP2. The R6mRNA that was detected
in HBoV1 RNA from infected cells (Dijkman et al., 2009) was predicted
to hybridize with the Cap probe at a size of 2.3 kb. The R7 mRNA,
which is similar to that encoding MVC and BPV1 capsid proteins, was
detected by RT-PCR in RNAs isolated from both transfection systems
(data not shown); it was predicted to hybridize with the Cap probe at
a size of 2.1 kb (Fig. 2A, lanes 2 and 3). Since the Northern blot did not
resolve the bands at sizes of 2.1, 2.2 and 2.4 kb very well, we assumeFig. 2. Transcription proﬁle of HBoV1 RNA. (A) Northern blot analysis of HBoV1 RNA. Total RN
cells, mRNAs puriﬁed from 5 or 20 µg of the total RNAs were loaded in the lane as indicated
which are diagramed at the bottom of panel B with their speciﬁc locations. The size of ea
illustrated in panel B. RNA maker ladder (Ambion) is shown in lane 1. The asterisk indicates
transcription map of HBoV1. The genome of HBoV1 is shown to scale with transcription land
2, A2 and A3) sites, the internal polyadenylation site [(pA)p], and the distal polyadenylatio
shown with their respective sizes (minus a poly A tail of approximately 150 nts). The puta
cleavage sites are shown by arrows with respective nucleotide numbers. HA-tagged ORFs athat all the R5, R6 and R7 are putative mRNAs to encode capsid
proteins (Fig. 3A).
The NS probe should detect all the species of HBoV1 RNAs because
they are generated from a single promoter and share the same ﬁrst
exon (only 60 nts). Similar to MVC and BPV1 RNAs, the ﬁrst exon is
short, and the NS probe hybridized to these ﬁrst-exon-containing
RNAs poorly; therefore, hybridization of HBoV1 RNAs with the NS
probe only revealed two abundant RNA species, i.e. R1M at 3.1 kb and
R2M at 4.8 kb (Fig. 2, lanes 4 and 5), both of which could encode NS1.
R1m RNA at 3.2 kb was not clearly detected in either HBoV1 RNA
sample.
Northern analysis with the whole HBoV1 genomic probe (NSCap)
revealed the overall HBoV1-generated RNA proﬁles from transfection
of both replicative and non-replicative plasmids (Fig. 2A, lanes 6 and
7, respectively). Eight major species of RNAs were detected, and these
were consistent in size with RNAs predicted to encode NS1 (R1M and
R2M mRNA at 3.1 and 4.8 kb, respectively), NS1-70 (R2m mRNA atAs were extracted from p5TRHBoV1-transfected 293 cells or pHBoV1-transfected A549
for Northern blot. The blots were hybridized to NS, Cap and NSCap probes, respectively,
ch detected bands is shown to the right of each lane. The identities of each band are
a band at approximately 1.8 kb, which was detected by all the three probes. (B) Putative
marks, including the P3 promoter, splice donor (D1, D2 and D3) and acceptor (A1-1, A1-
n site [(pA)d]. All of the RNA species are proposed from results of RT-PCR and RPA and
tive ORFs are diagramed with their predicated size in kDa of translated proteins. The
re indicated by a “diamond” symbol.
Fig. 3. Genetic map of HBoV1 and alignment of Bocavirus NS1 C-terminus. (A) A summarized genetic map of HBoV1 is shown with transcription landmarks in panel A. Six major
species of HBoV1 transcripts that were conﬁrmed by Northern blot analysis are shown with their relative abundance and sizes (minus a poly A tail of approximately 150 nts).
Proteins detected by transfection are indicated. (B) Comparison of the NS1 C-termini of HBoV1, BPV andMVC. The C-terminus aa 639–781 of HBoV NS1, aa 662–774 of MVC NS1, and
aa 733–860 BPV NS1 were chosen to align using ClustalW2 (Larkin et al., 2007). Identical amino acids are shown as a “star” symbol, while homology amino acids shown as two dots
under the amino acid sequences of the C-termini. Conserved motifs are underlined.
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VP1/2 (R5, R6 and R7 mRNA at 2.4, 2.2 and 2.1 kb, respectively). R3
and R4 mRNAs, both of which could encode NP1, are the most
abundant RNAs and account for approximately 50% of total HBoV1
RNAs (Fig. 2A, lanes 6 and 7, 1.3 and 3.0 kb). The overall abundance of
the R5, R6 and R7 capsid protein-encoding mRNAs constitute
approximately one third of total HBoV1 RNAs (Fig. 3A).
Although the A1-1 acceptor was shown by the RPA using a probe
spanning the acceptor, the R8 and R9 mRNAs, which may use
alternative polyadenylation, were not clearly hybridized as bands at
1.8 and 3.5 kb. Similar mRNAs were obvious on the Northern blot of
BPV-1 RNA but not on the blot with MVC RNA (Sun et al., 2009).
Interestingly, in HBoV1 RNAs extracted from infected cells, such
spliced R8 and R9 mRNAs were not detected by RT-PCR (Dijkman
et al., 2009). However, since tissue-speciﬁc splicing has been observed
in parvovirus MVM pre-mRNA processing (Choi et al., 2005), the
signiﬁcance of the R8 and R9 mRNAs awaits further investigation. A
band at approximately 1.8 kb, indicated by an asterisk in Fig. 2A, wasalways detected by all the three probes but not in RNAs extracted
frommock transfected cells (data not show). The nature of this 1.8 kb
band is currently unknown; however, a similar band was also
detected in Northern blot analysis of MVC RNA (Sun et al., 2009).
Summarizing results from RPA and Northern blot analysis, we
generated a genetic map of HBoV1, which is shown in Fig. 3A. Eight
major species of HBoV1 mRNAs are shownwith their respective sizes,
abundance in percentage and proteins to encode. This revised map is
very similar to that of MVC (Sun et al., 2009).
Expression of HBoV proteins
Next, we used the transcription map as a guide to proﬁle HBoV1
non-structural proteins expressed by transfection. First, we tagged an
HA-tag to the N-terminus of the NS1 ORF in the full length clone of
pHBoV1 to make HA-NS1-expressing plasmid pHBoV1(HA-NS1), and
an HA-tag to the C-terminus of the NP1 ORF in pHBoV1 to make NP1-
HA-expressing plasmid pHBoV1(NP1-HA). Transfection of pHBoV1
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(Fig. 4A), conﬁrming that R1M and R2MmRNAs encode the large NS1
protein, and R2m mRNA encodes the small NS1-70 protein.
Transfecting pHBoV1(NP1-HA) conﬁrmed the expression of NP1 at
approximately 26 kDa from R3 and R4 mRNA (Fig. 4A, lane 3).
Since a large size of the NS1 (at ∼100 kDa) was detected in cells
transfected with pHBoV1, we aligned the C-terminus of the NS1
proteins of HBoV1, BPV andMVC, as shown in Fig. 3B, using ClustalW2
(Larkin et al., 2007). The result showed that there are two conserved
motifs, 740WGERLGLI747 and 757PIVLXCFE764, present at the C-
terminus of the Bocavirus (Fig. 3B). We were not able to identify
similar motifs in the NCBI BLAST database (http://www.ncbi.nlm.nih.
gov/Structure/cdd/wrpsb.cgi), suggesting that they are highly con-
served motifs among members of the genus Bocavirus. However, the
search engine failed to identify any known domain with expected
value lower than 1. Nevertheless, the potential role of these highly
conserved motifs of Bocavirus NS1 C-terminus warrants further study.
To further conﬁrm results obtained from the two HA-tagged
constructs and the conserved C-terminus of the NS1, we raised
antiserum against the C-terminus of NS1, which shares a portion of
coding sequences with NP1 but in different frames, and antiserum
against the whole NP1, respectively. Western blot analysis of cell
lysate from pHBoV1-transfected cells with anti-NS1 (C-terminus)Fig. 4. Expression of HBoV proteins. (A) Western blot analysis of HBoV1 protein by transfect
indicated. Two days posttransfection, cells were lysed for Western blot using a monoclonal a
HBoV2 proteins by transfection. A549 cells were transfected with the nearly full-length clone
using anti-HBoV1NS1 (B), anti-HBoV1NP1 (C), and anti-HBoV1VP1/2, respectively. The iden
and 34 kDa that retain the C-terminus are shown as NS1*66 and NS1*34, respectively. pBluantiserum revealed three major bands, at approximately 100, 66 and
34 kDa, respectively (Fig. 4B, lane 2). The sizes of these bands were
conﬁrmed by resolving the NS1 proteins on SDS-6% and -12% PAGE
gels, respectively (Fig. 4B).
This antiserum did not react with the NS1-70 (Fig. 4B, lane 1). Thus
we have determined that the HBoV1 NS1 was expressed as a full
length protein of 100 kDa, and small proteins at 66 and 34 kDa,
respectively. The mechanism by which the C-terminal 66-kDa
(NS1*66) and 34-kDa (NS1*34) proteins were generated is currently
unknown. Interestingly, similar small NS1 proteins were detected in
pHBoV2-transfected cells (Fig. 4B, lane 3). The intact HBoV1 and
HBoV2 NS1 were detected at approximately 100 kDa rather than at
the putative size at 85 kDa (Sun et al., 2009), indicating a
modiﬁcation, perhaps phosphorylation, of both NS1. The sizes of
HBoV2 NS1 and NS1*66 were further conﬁrmed by resolving the NS1
proteins on an SDS-6%PAGE gel (Fig. 4B, 6%PAGE, lane 2). As expected,
the anti-HBoV1 NP1 antiserum detected both HBoV1 and HBoV2 NP1
at approximately 26 kDa in transfected cells (Fig. 4C, lanes 1 and 2),
suggesting they are not modiﬁed unlike the HBoV1 and 2 NS1
proteins.
We chose GST-fused HBoV1 VP1 peptide of aa 369–475 to generate
antiserum. In this region, two identical domains, aa 380–400/aa 376–
396 and aa 422–440/aa 418–436, are present both in HBoV1 andion of HA-tagged constructs. A549 cells were transfected with HA-tagged constructs as
ntibody against HA tag (HA-7, Sigma). (B, C and D) Western blot analysis of HBoV1 and
s of pHBoV1 and pHBoV2 as indicated. Two days later, cells were lysed for Western blot
tities of detected proteins are shown to the left on the blot. Small bands of the NS1 at 66
escript SK(+)-transfected cells were used as control (Ctrl).
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putative VP1 and VP2 of both HBoV1 and HBoV2 at approximately 72
and 60 kDa, respectively (Fig. 4D). The anti-VP1/2 antiserum cross
reacted with a cellular protein at a size of approximately 90 kDa as
indicated by an arrow (Fig. 4D). These results suggest a similar
expression of NS1, NP1 and VP1/2 between the two species of HBoV.
Moreover, the conserved expression of the small NS1*66 in cells
transfected with both pHBoV1 and pHBoV2 suggest that it must be
important in Bocavirus infection.
Proteins at sizes of 47 kDa, potentially expressed from putative R8
and R9 mRNAs, were not detected with anti-HA, anti-NS1 or anti-NP1
antiserum, further supporting that mRNA spliced at A1-1 may not be
signiﬁcant. In addition, protein bands at 17.5 and 8.8 kDa, which
include putative UP1 and UP2 ORFs, respectively, from the previously
identiﬁed map of HBoV1 generated from HBoV1-infected cells
(Fig. 2B) (Dijkman et al., 2009), were not detected in pHBoV1 and
2-transfected cells by either anti-NS1 (Fig. 4B, lanes 2 and 3) or anti-
HA (Fig. 4A, lanes 2 and 3).
A genetic map of HBoV1 summarizing the results of the
experiments so far described is shown in Fig. 3A. Collectively, R1M
and R2M mRNAs encode the large NS1 protein at a size of
approximately 100 kDa. The HBoV1 NS1 protein apparently was
modiﬁed, perhaps phosphorylated, since its coding capability is only
86 kDa. Interestingly, at least two small stable NS1 proteins, NS1*66
and NS1*34 at 66 and 34 kDa, respectively, were expressed by
transfection in A549 cells, which share the C-terminus with that of the
full length NS1.
Cellular localization of HBoV proteins
We next examined the cellular localization of HBoV1 proteins by
transfection of pHBoV1 in A549 cells. Staining with ant-NS1 C-
terminus antiserum showed a clear nuclear staining (Fig. 5, NS1),
suggesting that the NS1, NS1*66 and NS1*34 were localized in the
nucleus. Furthermore, anti-NP1 staining showed that the NP1 was
localized in the nucleus as well (Fig. 5, NP1). These results suggest that
the NS1 and NP1 of the HBoV1 have their potential function in HBoV
DNA replication, similar to those of MVC (Sun et al., 2009). The HBoV1
VP1 and VP2, as stained with anti-VP1/2 antiserum, were basically
localized in the nucleus with some diffused cytoplasmic staining
(Fig. 5, VP1/2), similar to the capsid proteins of other parvoviruses
(Vihinen-Ranta and Parish, 2006).
Expression of all HBoV1 proteins does not induce apoptosis or cell cycle
arrest
The large non-structural protein NS1 of other parvoviruses, e.g. the
NS1 of MVM, H-1 and B19V, has been shown to induce apoptosis and/
or cell cycle arrest of transfected cells (Brandenburger et al., 1990;
Daefﬂer et al., 2003; Ozawa et al., 1988; Rayet et al., 1998; Sol et al.,
1999). The cytopathic and cell cycle regulatory effect elicited duringFig. 5. Cellular localization of HBoV1 proteins by transfection. A549 cells were transfected wit
NP1 and anti-VP1/2, respectively. Confocal images were taken at ×60 magniﬁcation (objecti
as control (Control).viral infection is important in the virus life cycle, particularly for viral
DNA replication and virus egress. Therefore, we decided to examine
the apoptotic cell death and cell cycle regulation induced by HBoV1
viral proteins. We transfected the HBoV1 non-replicative construct
pHBoV1 into A549 cells. Transfected cells were analyzed for cell cycle
and apoptosis by DAPI and FLICA staining, respectively. Both NS1-
expressing and non-expressing cell populations were gated and
plotted for comparison (Fig. 6). Expression of the NS1, NS1*66,
NS1*34, NS1-70, NP1 and VP1/VP2 of HBoV1 in transfected cells were
detected by Western blot (Fig. 4). However, transfection of pHBoV1
did not induce an obvious cell cycle change and apoptotic cell death in
NS1 expressing cells (NS+) compared to those in NS1(−) cell
population [Fig. 6, compare numbers in NS+ with NS1(−)]. Active
caspase is a hallmark of apoptotic cell death (Degterev et al., 2003).
Thus, our results suggest that expression of both HBoV1 non-
structural and structural proteins does not induce an apparent
apoptosis or a perturbation of cell cycle progression in transfected
cells.
Discussion
HBoV RNA proﬁle
In this paper, we report a detailed characterization of the
expression proﬁle of Bocavirus HBoV1. The HBoV1 proﬁle was
obtained from RNAs following transfections. Analysis of HBoV1 RNA
produced during infection quantitatively by Northern or RNase
protection assay is currently precluded by the lack of isolated viruses
at a high load and the low efﬁciency of virus replication (Dijkman
et al., 2009). However, previous analysis of RNAs generated by
plasmid transfection of simian parvovirus (Liu et al., 2004), B19V
(Guan et al., 2008) and adeno-associated viruses (Qiu and Pintel,
2002; Qiu et al., 2002) show similar proﬁles to those seen in virus
infections. Our results showed that the overall transcription proﬁle of
HBoV1 is similar to that of two other Bocavirus members, MVC and
BPV1 (Sun et al., 2009; Qiu et al., 2007), in that all the species of
HBoV1 mRNAs are transcribed from a single promoter and further
processed through alternative splicing and alternative polyadenyla-
tion. These features are also similar to the transcription proﬁles of
members in the genera Erythrovirus and Amdovirus (Ozawa et al.,
1987; Liu et al., 2004; Qiu et al., 2006), which highlights the
importance of the regulation of alternative polyadenylation in the
expression of parvovirus genomes that have a single promoter (Qiu
and Pintel, 2008).
HBoV protein expression
We observed twomajor species of HBoV1mRNAs, the spliced R1M
and R2M mRNAs, in HBoV1 RNA from transfected cells. These mRNA
species were not recognized previously (Dijkman et al., 2009). The
R1M and R2M mRNAs were spliced at the small intron at a level ofh the pHBoV1 construct. At 48 h posttransfection, cells were stained with anti-NS1, anti-
ve lens). Nuclei were stained with DAPI. pBluescript SK(+)-transfected cells were used
Fig. 6. Expressing of HBoV1 proteins does not induce cell cycle arrest or activate
caspases. A549 cells were transfected with the pHBoV1. The transfected cells were
stained with DAPI and anti-NS1 for cell cycle analysis and pan-FLICA and anti-NS1 for
detection of apoptosis, respectively, at 48 h posttransfection. Numbers shown in DAPI
staining are percentage of cells at the G0/G1 phase, and numbers shown in FLICA
staining are percentage of pan-FLICA positive cells. A representative result is shown
from two independent experiments.
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which contains a C-terminus of aa 639–781, was detected in HBoV1
transfected cells. This result suggests that the NS1must be encoded by
the R1M and R2M mRNAs, through which the NS1 ORF extends its C-
terminus by removing the small intron (Fig. 3). The encoding
sequence of the extended NS1 C-terminus overlaps with the NP1-
encoding sequence, but in different frames. Moreover, both MVC and
BPV1 encode an NS1, which has the C-terminus-encoding sequences
overlapped with the NP1-encoding sequence (Qiu et al., 2007; Sun
et al., 2009). BPV1 NS1 protein is expressed at a size of approximately
100 kDa (Qiu et al., 2007). The large nonstructural protein NS1 of
parvovirus is a multifunctional protein that plays a key role in virus
replication. It possesses a site-speciﬁc DNA binding domain at the N-
terminus, a transcription activation domain at the C-terminus, and
enzymatic domains of ATPase and helicase in the middle (Cotmore
and Tattersall, 2006). The C-terminus of HBoV1 NS1 does not share
any similarities with that of the NS1 of other parvoviruses except for
the NS1 of MVC and BPV1. The NS1 C-terminus of the three Bocavirus
members shares 50% of consensus sequences and 27% identity,
especially the two conserved motifs, at the last 44 amino acids
(Fig. 3B). Therefore, we believe that the HBoV1 NS1 protein is most
likely a typical BocavirusNS1 protein thatmust have functions, such as
transactivation, in virus replication.
Two other non-structural proteins are expressed by HBoV1, NS1-
70 and NP1. NS1-70 is likely expressed from unspliced R2m mRNA.
The mid-ORF encoded NP1 was expressed at a high level following
transfection in comparison with NS1 (Fig. 4A), which is consistent
with the abundant level of R3 and R4 mRNAs (Fig. 3A). Unique to all
bocaviruses so far characterized is the expression of the mid-ORF-
encoded NP1. To our surprise, the NS1 of HBoV1 and HBoV2 are
expressed in different sizes, resulting in multiple bands on Western
blot analysis (Fig. 4B). Multiple bands centering at 45 kDa also were
observed in BPV1 infected cell lysates immunoprecipitated using
convalescent sera from BPV1-infected calves (Lederman et al., 1983).
Cleavage of AMDV NS1 has been proved to be essential and functional
for viral DNA replication (Best et al., 2003). The small bands
centralized at 66 kDa were present in both HBoV1 and 2 NS1
expression, suggesting that this small NS1*66 protein must play a
role during virus infection, which is currently under investigation.These multiple small proteins of NS1 might be translated from
alternative initiation sites or speciﬁcally cleaved by protease. The
exact mechanism by which these small NS1 proteins are produced
awaits further investigation.
Effect of HBoV proteins on cells
In parvoviruses, the large nonstructural proteins, NS1 (Nuesch and
Rommelaere, 2006; Rayet et al., 1998; Sol et al., 1999) or Rep 78
(Schmidt et al., 2000) are pro-apoptotic proteins. Recently, we have
identiﬁed the small nonstructural protein 11 kDa of B19V behaves as a
potent apoptosis-inducer during infection (Chen et al., 2010b).
Parvovirus infection-induced cell death often connects to the
pathogeneses of parvovirus infection, e.g., B19V infection-induced
cell death of erythroid progenitor cells of bonemarrow causes chronic
anemia in immunocompromised patients (Young and Brown, 2004).
We have recently identiﬁed capsid protein expression of AMDV
activates caspases (Cheng et al., 2010). Conversely, all the HBoV1
proteins, NS1, NS*66, NS*34, NS1-70, NP1 and VP1/VP2, do not induce
apoptosis by transfection (Fig. 6), which is similar to those proteins of
MVC, another member in genus Bocavirus (Chen et al., 2010a), and
maybe a common feature of the Bocavirus. We have recently identiﬁed
that replication of the MVC genome activates caspases that accounts
for MVC infection-induced apoptosis (Chen et al., 2010a). However,
currently an efﬁcient HBoV infection system has not been established;
whether HBoV1 or HBoV2 infection causes cell death and the role of
these proteins in the pathogenesis of HBoV infection await further
investigation.
Materials and methods
Cells and transfection
Human alveolar epithelial A549 cells (ATCC CCL-185), human
embryonic kidney 293 cells (ATCC CRL-10852) were maintained in
Dulbecco's modiﬁed Eagle's medium with 10% fetal calf serum in 5%
CO2 at 37 °C.
Transfection was performed using the Lipofetamine™ and Plus™
reagent (Invitrogen) or LipoD293 transfection reagent (SignaGen
Laboratories) following the manufacturers' instructions.
Plasmid constructs
HBoV constructs
Incomplete HBoV1 and HBoV2 genomes of 5299 nts were
ampliﬁed from DNA samples extracted from nasopharyngeal aspirate
and stool samples, respectively, with primers based on the published
HBoV1 sequence (Genbank accession no.: DQ000496) and HBoV2
sequence (Genbank accession no.: GQ200737), respectively. The
HBoV1 and HBoV2 DNAs (nt 1–5299) were cloned into XhoI/XbaI-
digested pBluescript SK(+) vector (Strategene), separately, which
resulted in pHBoV1 and pHBoV2, respectively. p5TRHBoV1 was made
by inserting the HBoV1 sequence (nt 1–5299) into an AAV5 ITRs-
containing plasmid, pAV5ITR (Guan et al., 2008); thus, in p5TRHBoV1,
the HBoV1 sequence was ﬂanked with AAV5 ITRs at two ends.
pHBoV1(HA-NS1) and pHBoV1(NP1-HA) were constructed by insert-
ing an HA tag into nt 259 at the N-terminus of the NS1 ORF and nt
3056 at the C-terminus of the NP1 ORF in pHBoV1, respectively.
pHBoV1(NS1-70-HA) was constructed by inserting the NS1-70 ORF of
HBoV1 (nt 253–2169) into BamHI/XhoI-digested pcDNA3CHA. The
pcDNA3CHA vector was constructed by inserting three repeated HA
tag between XhoI and XbaI sites into pcDNA3 (Stratagene).
Constructs for RNA probe generation
HBoV1 transcription units were mapped by HBoV1 probe clones,
created by inserting HBoV1 nt 161–320 (PD1), nt 854–1040 (PA1-2),
153A.Y. Chen et al. / Virology 403 (2010) 145–154nt 1998–2160 (PA1-2), nt 1998–2223 (PA1-2/D2), nt 2191–2434
(PA2/D3), nt 2961–3120 (PA3) and nt 3291–3440 [P(pA)p] sepa-
rately into BamHI/HindIII-digested pGEM4Z vector (Promega). These
probes are depicted in Fig. 1A.
Constructs for glutathione S-transferase (GST)-fusion expression
The HBoV1 NP1 ORF (nt 2410–3067), the C-terminus encoding
sequence (nt 2241–2666) of the HBoV1 NS1, and the C-terminus
encoding sequence (nt 4160–4480) of the HBoV1 VP1 were cloned
into pGEX4T3 (GE Health) as pGEX-HBoVNP1, pGEX-HBoVNS1(aa
640–781) and pGEX-HBoVVP1(aa 369–475), respectively.
All the nucleotide (nt) numbers of HBoV1 and HBoV2 refer to the
nucleotide (nt) numbers of the HBoV1 KU2 isolate (Genbank
accession no.: GQ925675) and HBoV2 KU1 isolate (Genbank accession
no.: GQ200737). The HBoV1 and HBoV2 genomes were sequenced at
the MCLab (www.mclab.com), and all the clones with probes or ORFs
were sequenced to ensure their ﬁdelities.
RNA isolation, RNase protection assay (RPA) and Northern blot analysis
p5TRHBoV1 was transfected with pHIVAV5Rep and pHelper
plasmids as previously described into 293 cells (Guan et al., 2008).
pHBoV1 was transfected into 60% to 80% conﬂuency of A549 cells.
Total RNA was isolated 48 h later by using Trizol reagent (Invitrogen).
From this total RNA, mRNA was further puriﬁed using the FastTrack
MAG Micro mRNA isolation kit (Invitrogen).
Probes were generated, and RPAs were performed as previously
described (Naeger et al., 1992; Schoborg and Pintel, 1991; Guan et al.,
2008). Northern analyses were performed exactly as previously
described (Pintel et al., 1983), using mRNA samples and 32P-labeled
DNA probes as indicated.
Antibody production
The antiserum production protocol has been described in our
previous publication (Sun et al., 2009). Proteins used for immunizing
animals were puriﬁed as GST-HBoV1NS1 (aa 640–781), GST-
HBoV1NP1 and GST-HBoV1VP1/2 (aa 369–475). All animal proce-
dures were approved by the KUMC IACUC.
SDS-PAGE, Western blotting and immunoﬂuorescence
SDS-PAGE, Western blotting and immunoﬂuorescence assay were
performed as described previously (Guan et al., 2008; Sun et al., 2009;
Qiu et al., 2000). Confocal imageswere taken at amagniﬁcation of 60×
(objective lens) with an Eclipse C1 Plus confocal microscope (Nikon)
and acquired by Nikon EZ-C1 software.
Flow cytometry analysis
FLICA (Fluorochrome-labeled inhibitor of caspase) assay
Cells were dissociated by 0.25% trypsin in Versene and stained
with carboxyﬂuorescein (FAM)-labeled FLICA peptides (Immuno-
chemistry Tech, MN), FAM-VAD-FMK (Poly-FLICA), as described
previously (Cheng et al., 2010).
For co-staining with anti-NS1 of HBoV1, ﬁxed cells were
permeabilized in PBS-2%FCS containing 0.2% Tween-20 (PBST) for
30 min, stained with a 1: 50 dilution of anti-NS1 antiserum, followed
by staining with a Cy5-labeled secondary antibody.
DAPI staining
Transfected cells were dissociated by 0.25% trypsin in Versene and
ﬁxed in 1% paraformaldehyde at RT for 30 min. The cells werewashed,
stained with DAPI, 4′,6-diamidino-2-phenylindole, at 20 µg/ml in
PBST, and then analyzed by ﬂow cytometry. Anti-NS1 costaining was
performed as described above.The samples were analyzed on a three-laser ﬂow cytometer (LSR II,
BD Biosciences) within an hour of staining at the Flow Cytometry Core
of the University of Kansas Medical Center. Flow cytometry data were
analyzed using FACS DIVA software (BD Biosciences).Acknowledgments
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